Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function
- 8 July 2005
- journal article
- research article
- Published by Taylor & Francis in Blood Pressure
- Vol. 14 (3) , 170-176
- https://doi.org/10.1080/08037050510008959
Abstract
This study compared the use of antihypertensive treatment and blood pressure (BP) controls between patients with diabetic kidney disease (DK+) and patients with non‐diabetic kidney disease (DK−) exhibiting moderate‐to‐severe chronic renal failure who did not need renal replacement therapy. A cross‐sectional survey included all renal patients with s‐creatinine at ⩾200 µmol/l attending regular control sessions at six renal units in Norway. Of the 351 patients included, 73 (20.8%) were DK+. The proportion reaching a BP goal of p = 0.92), while 38% and 39% achieved a BP of p = 0.001). Thus, despite the use of multiple antihypertensive drugs, controlling BP – especially the systolic BP – is difficult in high‐risk patients with chronic renal failure caused by diabetic kidney disease.Keywords
This publication has 11 references indexed in Scilit:
- Role of excess volume in the pathophysiology of hypertension in chronic kidney diseaseKidney International, 2003
- Combination Therapy With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in the Treatment of Patients With Type 2 Diabetes MellitusArchives of internal medicine (1960), 2003
- RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trialThe Lancet, 2003
- Association of calcium channel blockers and mortality in haemodialysis patientsClinical Science, 2002
- Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokesKidney International, 2002
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive NephrosclerosisA Randomized Controlled TrialJAMA, 2001
- Sympathetic overactivity and arterial hypertension in renal failureNephrology Dialysis Transplantation, 2001
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyThe Lancet, 1997
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976